Scott Dunseth Myers's Net Worth
$4.94 Million
Who is Scott Dunseth Myers?
Scott Dunseth Myers has an estimated net worth of $4.94 Million. This is based on reported shares across multiple companies, which include Cascadian Therapeutics, Inc., DYNAVAX TECHNOLOGIES CORP, Harpoon Therapeutics, Inc., Cartesian Therapeutics, Inc., Trillium Therapeutics Inc., AMAG PHARMACEUTICALS, INC., Viridian Therapeutics, Inc.\DE, and DOV PHARMACEUTICAL INC.
SEC CIK
Scott Dunseth Myers's CIK is 0001356256
Past Insider Trading and Trends
2023 was Scott Dunseth Myers's most active year for acquiring shares with 12 total transactions. Scott Dunseth Myers's most active month to acquire stocks was the month of April. 2018 was Scott Dunseth Myers's most active year for disposing of shares, totalling 10 transactions. Scott Dunseth Myers's most active month to dispose stocks was the month of February. 2023 saw Scott Dunseth Myers paying a total of $261,803.25 for 1,502,213 shares, this is the most they've acquired in one year. In 2023 Scott Dunseth Myers cashed out on 207,500 shares for a total of $81,375.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cascadian Therapeutics, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -56.79K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +14.22% | 7.07K |
$3.92 | -$13,441.68 | 56.79K |
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
| +12.44% | 5.5K |
$3.74 | $20,542.50 | 49.72K |
Aug 11
| |||
Form 4
| +6.76% | 2.8K |
$4.00 | $11,191.60 | 44.22K |
May 12
| |||
Form 4
| +5.07% | 2K |
$4.11 | $8,228.60 | 41.42K |
Mar 31
| |||
Form 4
| +2.60% | 1K |
$3.93 | $3,927.10 | 39.42K |
Mar 20
| |||
Form 4
| +114.42% | 20.5K |
$3.76 | $77,039.00 | 38.42K |
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +72.00% | 45K |
$1.15 | $51,745.50 | 107.5K |
Aug 17
| |||
Form 4
|
∞
| 62.5K |
$0.80 | $50,000.00 | 62.5K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.915
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.36% | 5.36K |
—
|
—
| 20.09K |
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.335
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.66K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +9.93% | 2.05K |
—
|
—
| 22.67K |
Jan 1
| |||
Form 4
| +32.01% | 5K |
—
|
—
| 20.62K |
Nov 27
| |||
Form 4
| +59.03% | 5.8K |
—
|
—
| 15.62K |
Oct 1
| |||
Form 4
| +56.94% | 35.63K |
—
|
—
| 98.22K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +126.28% | 34.92K |
—
|
—
| 62.58K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cartesian Therapeutics, Inc. (RNAC) Snapshot price: $0.6484
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +95.11% | 39.41K |
$1.46 | $57,537.14 | 80.84K |
Dec 23
| |||
Form 4
|
∞
| 41.44K |
$1.81 | $74,999.16 | 41.44K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trillium Therapeutics Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||